180 Life Sciences announces completion of approximately $156 million private placement to purchase ETH

According to Golden Finance, 180 Life Sciences Corp. (NASDAQ: ATNF) announced that it has sold approximately $156 million in 2028 senior secured convertible bonds ("Convertible Bonds") to an institutional investor through private placement on August 8th. The company plans to use the net proceeds from the issuance of convertible bonds to purchase more ETH. This issuance further expands the company's recently announced ETH fund management strategy. The company plans to regularly update investors on its ETH holdings in the short term to ensure maximum transparency.